It has been reported that by repressing miR-26a, MYC stimulates EZH2 expression in Burkitt lymphoma cells, highlighting how EZH2 deregulation is interconnected with c-MYC-driven tumorigenesis [57]. The gene discussed is EZH2; the disease is Burkitt lymphoma.